Medical information Clinical review pending

Genetic Testing

TIMP1 Gene Bicuspid Aortic Valve Genetic Test

The TIMP1 Gene Bicuspid Aortic Valve NGS Genetic DNA Test identifies genetic predispositions to cardiovascular disorders, particularly those linked to bicuspid aortic valves. This test is valuable for individuals with a family history of heart conditions, offering early insights into potential health risks.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
Results: Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation: No specific fasting is required. A clinical history and genetic counseling session, including pedigree chart creation, are recommended before testing. Confirm specific requirements with the laboratory before booking.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the TIMP1 Gene Bicuspid Aortic Valve Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Family history of bicuspid aortic valve
✓Family history of related cardiovascular conditions
✓Individuals with symptoms suggestive of heart conditions (e.g., shortness of breath, chest pain)
✓Patients with known cardiovascular risk factors
✓Personal history of bicuspid aortic valve

In plain language

What this test helps you understand

This test helps identify individuals with genetic variations in the TIMP1 gene associated with an increased risk of developing cardiovascular conditions, particularly bicuspid aortic valve. It aids in risk assessment and informs preventive healthcare strategies.

The TIMP1 Gene Bicuspid Aortic Valve NGS Genetic DNA Test is an advanced diagnostic tool using Next Generation Sequencing (NGS) to analyze genetic factors related to cardiovascular health. It specifically looks for variations in the TIMP1 gene, which may be associated with an increased risk of developing conditions like bicuspid aortic valve. Understanding these genetic markers can help healthcare providers assess risk and guide preventive strategies. This test is particularly relevant for individuals with a family history of bicuspid aortic valve or related heart conditions. Early detection through genetic testing can lead to informed decisions about lifestyle modifications and medical management, potentially improving long-term health outcomes. Results are interpreted by qualified genetic counselors to help you and your doctor develop a personalized health plan.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific fasting is required. A clinical history and genetic counseling session, including pedigree chart creation, are recommended before testing. Confirm specific requirements with the laboratory before booking.

SampleBlood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.

MethodologyNext Generation Sequencing (NGS) is used to analyze the TIMP1 gene for relevant genetic variations.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test analyzes specific variations in the TIMP1 gene. It does not detect all possible genetic causes of cardiovascular conditions. A negative result does not completely rule out the risk of developing these conditions. Results should be interpreted in the context of clinical findings and family history.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

A bicuspid aortic valve is a heart defect where the aortic valve has two leaflets instead of the usual three. This test looks for genetic links to this condition.

This test is often recommended for individuals with a family history of bicuspid aortic valve or related heart conditions, or those with symptoms suggestive of heart problems.

The TIMP1 gene provides instructions for making a protein that helps regulate the breakdown of the extracellular matrix, which is important for tissue structure and function, including in the heart and blood vessels.

Results are interpreted by qualified genetic counselors who can explain the findings in the context of your personal and family medical history.

Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.

It is recommended to discuss your results with your doctor or a genetic counselor to understand their implications for your health and potential management strategies.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp